Dengue Testing Market Dynamics and Developments by 2031

Historic Data: 2021-2023   |   Base Year: 2024   |   Forecast Period: 2025-2031

Dengue Testing Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage : by Product Type (ELISA-Based Tests, RT-PCR Based Tests, Dengue IgG/IgM Rapid Test, Other Tests); End-User (Hospitals, Diagnostic Centers, Other End-Users); and Geography (North America, Europe, Asia Pacific, and South and Central America)

  • Report Date : Oct 2025
  • Report Code : TIPRE00040600
  • Category : Life Sciences
  • Status : Upcoming
  • Available Report Formats : pdf-format excel-format
  • No. of Pages : 150
Page Updated: Mar 2025

The Dengue Testing Market is expected to register a CAGR of 5.5% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031.

The report is segmented by Product Type (ELISA-Based Tests, RT-PCR Based Tests, Dengue IgG/IgM Rapid Test, and Other Tests).The report further presents analysis based on the End-User (Hospitals, Diagnostic Centers, and Other End-Users). The global analysis is further broken-down at regional level and major countries. The Report Offers the Value in USD for the above analysis and segments.

Purpose of the Report

The report Dengue Testing Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:

  • Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
  • Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
  • Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.

Dengue Testing Market Segmentation

Product Type

  • ELISA-Based Tests
  • RT-PCR Based Tests
  • Dengue IgG/IgM Rapid Test
  • Other Tests

End-User

  • Hospitals
  • Diagnostic Centers
  • Other End-Users

Customize This Report To Suit Your Requirement

You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities

Dengue Testing Market: Strategic Insights

dengue-testing-market
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Dengue Testing Market Growth Drivers

  • Rise in Dengue Infections Cases: The global increase in dengue cases, which can be attributed to urbanization, climate change, and the growth of the mosquito population, is a key factor driving the dengue testing market. As it spreads to new areas worldwide, especially tropical and subtropical regions, there is increasing demand for accurate, rapid, and affordable diagnostic tests, resulting in the accelerated growth of the market.
  • Advancements in Diagnostic Solutions: Advances in diagnostic technology, for example, improved serological tests, antigen detection assays, and PCR-based methods, are making tests more sensitive and specific. This would allow rapid detection and would reduce the diagnostic delay, thereby ensuring early medical intervention. Besides, point-of-care tests that require very minimal equipment enhance market growth, especially in resource-constrained settings.
  • Government Initiatives and Public Awareness: Dengue prevention, detection, and surveillance activities have been increasing at government and public health levels. National awareness campaigns on dengue, investment in diagnostic infrastructure, and research expenditure have also been included. With an increase in public awareness and coupled with efforts towards such surveillance, the need for a proper testing solution will arise, thus enhancing the earlier detection and curbing outbreaks.

Dengue Testing Market Future Trends

  • Trend to point-of-care testing: Point-of-care testing is the emerging trend of the dengue testing market. POC tests enable speedy results at or near the patient's location, therefore expediting the diagnosis and treatment process. It favors the patient in rural or remote locations with poor access to healthcare infrastructure, thereby encouraging increased use across all geographies.
  • Integration of mHealth solutions: The integration of mHealth solutions with diagnostic solutions for dengue fever is becoming trendy. Through mobile platforms, health workers help monitor outbreaks at the real-time level, report results of tests, and collect data for sharing at the real-time level. This is mainly seen in resource-poor settings, whereby smartphones or other mobile devices become instruments in diagnosis and surveillance.
  • Demand is high for multiplex testing: The multiplex test is becoming popular, which can detect multiple infections in the same instance, including dengue, Zika, and chikungunya. These tests reduce time and cost as it identifies different vector-borne diseases in a single process. They are highly valuable in regions where these diseases frequently co-occur, thereby improving diagnostic efficiency.

Dengue Testing Market Opportunities

  • Expansion in Emerging Markets:Developing and coming into the markets of fast-growing regions such as Southeast Asia, Latin America, and Africa, dengue testing companies have a major source of growth. As more cases of dengue cases arise in these regions, the demand for affordable, accessible diagnostic solutions is mounting. Thus, by coming up with cost-effective easy to use tests, it could significantly expand market share.
  • Development of Cost-Effective Diagnostic Kits: An increased scope for developing low-cost, high-performance diagnostic tests, particularly in point-of-care settings. Innovation in rapid diagnostic kits with high sensitivity and specificity will address the need for cost-effective solutions in low- and middle-income countries and create new streams of revenue for market players.
  • Partnership with Governments and NGOs: Cooperation with government institutions and non-governmental organizations, which deal with disease control, may open up useful expansion opportunities. Such cooperation can be with public health initiatives, testing programs of huge volumes, and funding research and development in the said regions, creating opportunities for companies to increase their reach in endemic countries.

Dengue Testing Market Regional Insights

The regional trends and factors influencing the Dengue Testing Market throughout the forecast period have been thoroughly explained by the analysts at The Insight Partners. This section also discusses Dengue Testing Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

Dengue Testing Market Report Scope

Report Attribute Details
Market size in 2024 US$ XX million
Market Size by 2031 US$ XX Million
Global CAGR (2025 - 2031) 5.5%
Historical Data 2021-2023
Forecast period 2025-2031
Segments Covered By Product Type
  • ELISA-Based Tests
  • RT-PCR Based Tests
  • Dengue IgG/IgM Rapid Test
  • Other Tests
By End-User
  • Hospitals
  • Diagnostic Centers
  • Other End-Users
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Abbott Laboratories
  • BD(Becton, Dickinson and Company)
  • BioMérieux
  • Alere Inc.
  • MedMira
  • Chembio Diagnostics
  • Tecan Group
  • DiaSorin
  • Premier Medical Corporation
  • Enzo Life Sciences

  • Dengue Testing Market Players Density: Understanding Its Impact on Business Dynamics

    The Dengue Testing Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.


    dengue-testing-market-cagr

    • Get the Dengue Testing Market top key players overview

    Key Selling Points

    • Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Dengue Testing Market, providing a holistic landscape.
    • Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
    • Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
    • Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.

    The research report on the Dengue Testing Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.


    Frequently Asked Questions

    1
    What is driving the growth of the dengue testing market?
    The major growth driver of the dengue testing market is the rising global prevalence of dengue cases, technological advancement in diagnostic tools, and government initiatives aimed at improving disease detection and public health
    2
    What are the Major diagnostic methods used for dengue testing?
    The main diagnostic tests for dengue include serological tests (such as IgM/IgG ELISA), antigen detection tests (NS1), and molecular tests like RT-PCR.
    3
    How does point-of-care testing affect the dengue testing market?
    Point-of-care testing has the advantage of quicker diagnosis and treatment, especially in remote or underserved areas.
    4
    What are the challenges faced by the dengue testing market?
    Challenges include the higher cost of advanced diagnostic equipment and limited access to some regions' healthcare infrastructure
    5
    Which regions dominates the dengue diagnostic testing market?
    The primary regions that would drive demand are those that have high dengue incidence rates, including Southeast Asia, Latin America, and parts of Africa.
    6
    How are mobile health tools changing dengue diagnostics?
    Mobile health tools are improving the dengue diagnostic process as they allow healthcare providers to get results quickly, track outbreaks in real-time, and share data efficiently in places where diagnostic infrastructure is not that great.
    Mrinal Kerhalkar
    Manager,
    Market Research & Consulting

    Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

    Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

    • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
    • PEST and SWOT Analysis
    • Market Size Value / Volume - Global, Regional, Country
    • Industry and Competitive Landscape
    • Excel Dataset

    Testimonials

    Reason to Buy

    • Informed Decision-Making
    • Understanding Market Dynamics
    • Competitive Analysis
    • Identifying Emerging Markets
    • Customer Insights
    • Market Forecasts
    • Risk Mitigation
    • Boosting Operational Efficiency
    • Strategic Planning
    • Investment Justification
    • Tracking Industry Innovations
    • Aligning with Regulatory Trends
    Your Key Concerns Addressed - Question & Answer
    Can I view a sample of the report before purchasing?

    Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.

    Is analyst support included with the purchase?

    Absolutely - analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.

    What are the next steps once I place an order?

    Once your order is successfully placed, you will receive a confirmation email along with your invoice.

    • For published reports: You'll receive access to the report within 4-6 working hours via a secured email sent to your email.
    • For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.

    Can the report be tailored to suit my specific needs?

    We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we'll be happy to provide a customized proposal or scope.

    In what format is the report delivered?

    The report is available in either PDF format or as an Excel dataset, depending on the license you choose.

    The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
    Please review the license options at checkout or contact us to confirm which formats are included with your purchase.

    How secure is the payment process on your platform?

    Our payment process is fully secure and PCI-DSS compliant.

    We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
    You can make your purchase with confidence, knowing your personal and financial information is safe with us.

    Do you provide special pricing for buying multiple reports?

    Yes, we do offer special pricing for bulk purchases.
    If you're interested in purchasing multiple reports, we're happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you're considering, and we’ll share a personalized quote.

    Can I connect with your team to discuss the report before buying?

    Yes, absolutely.
    Our team is available to help you make an informed decision. Whether you have questions about the report’s scope, methodology, customization options, or which license suits you best, we're here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.

    Will I get a billing invoice upon purchase?

    Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
    If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we’ll be happy to assist.

    Is there support available if I can't access my report?

    Yes, certainly.
    If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we'll ensure the issue is resolved quickly so you can access your report without interruption.

    Our Clients

    • Abbott Laboratories

    • BD(Becton, Dickinson and Company)

    • BioM?rieux

    • Alere Inc.

    • MedMira

    • Chembio Diagnostics

    • Tecan Group

    • DiaSorin

    • Premier Medical Corporation

    • Enzo Life Sciences

    Sales Assistance
    US: +1-646-491-9876
    UK: +44-20-8125-4005
    Email: sales@theinsightpartners.com
    Chat with us
    DUNS Logo
    87-673-9708
    ISO Certified Logo
    ISO 9001:2015
    ISO Certified Logo